It has also been shown that the expression of AnxA6 and GRF2 are epigenetically modulated in some cancers [13, 34], and that inhibition of Ca2+ signaling influences the expression of tumor suppressor genes via epigenetic mechanisms [35]. Here, RASGRF2 is linked to neoplasm.